KM Research Hub
← 返回论文库
待处理 入排:符合 图源:待检查 入排置信度 0.98

Impact of pre-chemotherapy food intake on chemotherapy-induced nausea and vomiting in patients with early breast cancer: a subanalysis of the randomized SUCCESS C trial.

Henning Schäffler, Manuel Hörner, Lothar Häberle, Chloë Goossens, Kerstin Pfister, Elena Leinert, Kristina Veselinovic, Sara Y Brucker, Uwe Köhler, Georg Heinrich, Andreas Schneeweiss, Matthias W Beckmann, Peter A Fasching, Wolfgang W Janni, Brigitte Rack, Sabine Heublein, Philipp Ziegler

Support Care Cancer 34(12) 1223

PMID43026373
PMCIDPMC13768299
DOI10.1007/s00520-026-11437-9
发表日期2026-11-13
入排依据:原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。
摘要

摘要

PURPOSE: Chemotherapy-induced nausea and vomiting (CINV) remains a challenging side effect, significantly impacting patients' quality of life [1-3]. Knowledge of eating behaviour's influence on CINV is still limited. This study improves the understanding of CINV by investigating the impact of pre-chemotherapy food intake within the randomized Phase III SUCCESS C trial. METHODS: The SUCCESS C trial (NCT00847444), enrolled ,463 women with early-stage, HER2-negative breast cancer, receiving either three cycles of 5-fluorouracil (500 mg/m2), epirubicin (100 mg/m2), and cyclophosphamide (500 mg/m2) followed by three cycles of docetaxel (100 mg/m2) every 3 weeks (FEC), or six cycles of docetaxel (75 mg/m2) and cyclophosphamide (600 mg/m2) (TC). The present analysis included patients with completed CINV diary with hourly documentation over 5 days post-chemotherapy. RESULTS: CINV diary data during chemotherapy cycles 1-3 were available for 1582 patients, of whom 814 received FEC and 768 TC. Patient characteristics between chemotherapy arms were comparable. For FEC, pre-chemotherapy eating behaviour had a significant impact on nausea-free survival (NFS) in cycle 1 (p = 0.04) and on emesis-free survival (EFS) in cycle 2 (p = 0.02). For TC, no effect on NFS, but a significant effect on EFS (p = 0.04 in cycle 1; p < 0.01 in cycle 2), was observed. Median EFS was approximately 120 h for all cycles and treatments. CONCLUSION: This analysis demonstrates in both regimens less emesis, and for FEC less nausea, of patients with pre-chemotherapy food intake. The effect was most pronounced during the first 24 h after chemotherapy administration. Thus, eating behaviour influences CINV outcomes and warrants further evaluation.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。